A collaborative study led by researchers in Arizona found that a new blood test improves early detection of Alzheimer's ...

A Columbia University study suggests that combining p-tau217 blood tests with APOE4 genetic testing may help predict the onset of Alzheimer's disease symptoms.

Along with knowing more about Alzheimer’s disease, public education needs to openly address the option of not having to live ...

Alzheimer’s disease (AD) is a heterogeneous disorder with multiple etiologies. Harnessing the immune system by blocking the programmed cell death receptor (PD)-1 pathway in an amyloid beta mouse model ...

Tony Bennett’s Alzheimer’s diagnosis became public in 2021, although his family said he had been diagnosed in 2016. The ...

The pathology of Alzheimer's disease has an inflammatory component that is characterized by upregulation of proinflammatory cytokines, particularly in response to amyloid-β (Aβ). Using the APPPS1 ...

Researchers at Washington University School of Medicine in St. Louis have developed a potential antibody-based approach to ...

A new routine blood test developed by researchers in Arizona could provide faster and cheaper Alzheimer's disease diagnoses ...

The latest approvals expand the population of people who could be tested for the memory disorder—but experts warn the tests aren't for everyone.

Ultrahigh-performance liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS) tracks blood metabolite changes after repetitive transcranial magnetic stimulation (rTMS)-cognitive training therapy.

Alzheimer’s R&D is shifting toward disease modification, with amyloid, tau, RNA and immune targets driving trials, partnerships and oral therapy opportunities.Dublin, Sept. (GLOBE NEWSWIRE) -- ...

The following is a repost from Facebook by Professor Takayoshi Shimohata, Department of Neurology, Gifu University Graduate ...